Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
US Stocks Move: Nektar Therapeutics rises another 3% pre-market as alopecia areata drug trial meets expected results

US Stocks Move: Nektar Therapeutics rises another 3% pre-market as alopecia areata drug trial meets expected results

格隆汇格隆汇2026/04/21 08:37
Show original
Glonghui, April 21 ― A certain exchange continued to rise 3.53% in pre-market trading for U.S. stocks today, closing at $103.89. Yesterday, the stock saw a large gain of 18.25% to close at $100.35, up 1.37 times year-to-date.On the news side, on April 20, the exchange announced top-line results from the 52-week extension of the phase 2b REZOLVE-AA study of its alopecia areata treatment drug, rezpegaldesleukin, after a 16-week extension. Data showed that in the 18 µg/kg and 24 µg/kg dose groups, 29% and 31% of patients, respectively, achieved a new SALT score ≤20 from week 36 to week 52, and 94% of patients completed treatment extension with clinically meaningful hair regrowth.After the release of the long-term extension results of the alopecia study, Oppenheimer reiterated its “Outperform” rating and $140 target price for the exchange, stating that the overall SALT ≤20 response rate in the 24 µg/kg dose group at week 52 was about 28%, in line with its best expected range.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Major Transformation in Microsoft Financial Reporting: Azure Revenue to be Disclosed Quarterly, Merged with Office Business under "Agents and Infra"

Microsoft has announced it will start disclosing specific quarterly revenues for its Azure cloud computing business, with the latest fiscal quarter reaching $29.4 billion, demonstrating continued expansion. The market regards Azure as an important indicator for Microsoft's AI business, and analysts have previously had difficulty accurately valuing it due to insufficient information. At the same time, the company has adjusted its financial reporting structure by merging cloud computing and Office businesses, with the new division directly named "Agents and Infra," highlighting its AI strategic intent.

华尔街见闻2026/09/02 23:26